Acorda Therapeutics, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Acorda Therapeutics, Inc. reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $212.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2024-04-01
- Acorda Therapeutics, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $212.00K, a 59.40% increase from fiscal 2022.
- Acorda Therapeutics, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $133.00K, a 81.60% decline from fiscal 2021.
- Acorda Therapeutics, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $723.00K, a 1290.38% increase from fiscal 2020.
- Acorda Therapeutics, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $52.00K, a 53.98% decline from fiscal 2019.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $212.00K 10-K · filed 2024-04-01 |
| 2022-12-31 | $133.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $723.00K 10-K · filed 2023-03-15 |
| 2020-12-31 | $52.00K 10-K · filed 2022-03-18 |
| 2019-12-31 | $113.00K 10-K · filed 2021-03-16 |
| 2018-12-31 | $194.00K 10-K · filed 2020-02-28 |
| 2017-12-31 | $146.00K 10-K · filed 2020-02-28 |
| 2014-12-31 | $200.00K 10-K · filed 2017-02-27 |
| 2013-12-31 | $511.00K 10-K · filed 2016-02-29 |